What's in a name? Medication terms: What they mean and when to use them

British Journal of Ophthalmology

Volumn 91, Issue 11, 2007, Pages 1244-1424

  Wride, Nicholas ^a   Finch, Tracy ^b   Rapley, Tim ^b   Moreira, Tiago ^c   May, Carl ^b   Fraser, Scott ^a  

^a SUNDERLAND EYE INFIRMARY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c DURHAM UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; DRUG;

ALCOHOLISM; COMPREHENSION; DOCTOR PATIENT RELATION; DRUG NOMENCLATURE; GLAUCOMA; HOMELESSNESS; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; LANGUAGE; MENTAL DISEASE; MONEY; NOTE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT REFUSAL; TUBERCULOSIS; DRUG THERAPY; NOMENCLATURE; PRESCRIPTION; PSYCHOLOGICAL ASPECT; REVIEW;

DRUG THERAPY; HUMANS; PATIENT COMPLIANCE; PHARMACEUTICAL PREPARATIONS; PHYSICIAN-PATIENT RELATIONS; PRESCRIPTIONS, DRUG; TERMINOLOGY AS TOPIC;

EID: 35748976215     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2007.118117     Document Type: Note

References (26)

1. Sackett DL, Snow JC. The magnitude of adherence and nonadherence. In: Haynes RB, Taylor DW, Sackett DL, eds. Compliance in health care.Baltimore: Johns Hopkins University Press, 1979:11-22.
2. Turnbull F. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003;362:1527-35.
3. The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7, the relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 2000;130:429-40.
4. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotension medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:701-13.
5. McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 2002;36:1331- 6.
6. Adherence to long-term therapies: evidence for action. In: Sabate E, ed. Geneva: World Health Organization, 2003, available at http://www.emro.who.int. ncd/Publications/adherence_report.pdf.
7. Foster JP. Detention institutes for ignorant and vicious consumptives. Transaction of the National Association for the Study and Prevention of Tuberculosis. 1905;1:333-8.
8. Lemer BH, Gulick RM, Dubler NN. Rethinking nonadherence: historical perspectives on triple-drug therapy for HIV disease. Ann Intern Med 1998;129:573-8.
9. Northrop C. The practical management of the recalcitrant tuberculous patient. Public Health Rep 1952;67:894-8.
10. Collins Softback English Dictionary, 3rd edn. Glasgow: HarperCollins Publishers, 1991.
11. Jenkins BW. Are patients true to t.i.d. and q.i.d. doses? General Practice 1954;9:66-9.
12. Dixon WM, Stradling P, Wootton ID. Outpatient PAS therapy. Lancet 957;2:871-2.
13. Lemer BH. Temporarily detained: tuberculous alcoholics in Seattle, 1949 through 1960. Am J Public Health 1996;86:257-65.
14. Osterberg L, Blaschke T. Drug therapy: adherence to medication. N Engl J Med 2005;353:487-97.
15. Dickinson D, Raynor DK. What information do patients need about medicines? Ask the patients - they may want to know more than you think. BMJ 2003;327:861.
16. Donovan JL. Patient decision making. The missing ingredient in compliance among well-controlled hypertensive patients. J Clin Epidemiol 1991;44:1361-71.
17. Conrad P. The meaning of medications: another look at compliance. Soc Sci Med 1988;27:1299-308.
18. Cramer JA, Scheyer RD, Mattson RH. Compliance declines between clinic visits. Arch Intern Med 1990;150:1509-10.
19. Eddy DM. Clinical decision making: from theory to practice. Designing a practice policy. Standards, guidelines, and options. JAMA, 1990;263:3077, 3081, 3084.
20. Hoynes RB, Yao X, Degani A, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev, 2005, (4) CD00011.DOI: 10.1002/14651858.CD000011.pub2..
21. Nordstrom BL, Friedman DS, Mozaffari E, et al. Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol 2005;140:598-606.
22. Walley JD, Khan MA, Newell JN, et al. Effectiveness of the direct observation component of DOTS for tuberculosis: a randomised controlled trial in Pakistan. Lancet 2001;357:664-9.
23. Steiner JF, Fihn SD, Blair B, et al. Appropriate reductions in compliance among well-controlled hypertensive patients. J Clin Epidemiol 1991;44:1361-71.
24. Horwitz RI, Horwitz SM. Adherence to treatment and health outcomes. Arch Intern Med 1993;153:1863-8.
25. Marinker M, Shaw J. Not to be taken as directed. BMJ 2003;326:348-9.
26. Steiner JF, Earnest MA. The language of medication-taking. Ann Intern Med 2000;132:926-30.